These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26862208)

  • 1. Specificity and disease in the ubiquitin system.
    Chaugule VK; Walden H
    Biochem Soc Trans; 2016 Feb; 44(1):212-27. PubMed ID: 26862208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of a HOIP/E2~ubiquitin complex reveals RBR E3 ligase mechanism and regulation.
    Lechtenberg BC; Rajput A; Sanishvili R; Dobaczewska MK; Ware CF; Mace PD; Riedl SJ
    Nature; 2016 Jan; 529(7587):546-50. PubMed ID: 26789245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-substrate relationships in the ubiquitin system: approaches for identifying substrates of ubiquitin ligases.
    O'Connor HF; Huibregtse JM
    Cell Mol Life Sci; 2017 Sep; 74(18):3363-3375. PubMed ID: 28455558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chain reactions: molecular mechanisms of RBR ubiquitin ligases.
    Cotton TR; Lechtenberg BC
    Biochem Soc Trans; 2020 Aug; 48(4):1737-1750. PubMed ID: 32677670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of various DNA repair pathways by E3 ubiquitin ligases.
    Natarajan C; Takeda K
    J Cancer Res Ther; 2017; 13(2):157-169. PubMed ID: 28643728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic approaches to identify E3 ligase substrates.
    Iconomou M; Saunders DN
    Biochem J; 2016 Nov; 473(22):4083-4101. PubMed ID: 27834739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkin: a multifaceted ubiquitin ligase.
    Moore DJ
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):749-53. PubMed ID: 17052189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of E2~ubiquitin conjugates for the characterization of ubiquitin transfer by RING E3 ligases such as the inhibitor of apoptosis proteins.
    Middleton AJ; Budhidarmo R; Day CL
    Methods Enzymol; 2014; 545():243-63. PubMed ID: 25065893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ubiquitin ligase is deficient in Fanconi anemia.
    Meetei AR; de Winter JP; Medhurst AL; Wallisch M; Waisfisz Q; van de Vrugt HJ; Oostra AB; Yan Z; Ling C; Bishop CE; Hoatlin ME; Joenje H; Wang W
    Nat Genet; 2003 Oct; 35(2):165-70. PubMed ID: 12973351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBR ligase-mediated ubiquitin transfer: a tale with many twists and turns.
    Walden H; Rittinger K
    Nat Struct Mol Biol; 2018 Jun; 25(6):440-445. PubMed ID: 29735995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impairment of the ubiquitin-proteasome system and neurodegeneration].
    Tanaka K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Apr; 26(2):67-73. PubMed ID: 16722463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational modification profiling - A novel tool for mapping the protein modification landscape in cancer.
    Eisenberg-Lerner A; Ciechanover A; Merbl Y
    Exp Biol Med (Maywood); 2016 Aug; 241(14):1475-82. PubMed ID: 27229346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of DNA repair by parkin.
    Kao SY
    Biochem Biophys Res Commun; 2009 May; 382(2):321-5. PubMed ID: 19285961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of the host ubiquitome by bacterial enzymes.
    Berglund J; Gjondrekaj R; Verney E; Maupin-Furlow JA; Edelmann MJ
    Microbiol Res; 2020 May; 235():126429. PubMed ID: 32109687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dedicated to the core: understanding the Fanconi anemia complex.
    Gurtan AM; D'Andrea AD
    DNA Repair (Amst); 2006 Sep; 5(9-10):1119-25. PubMed ID: 16784902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymes of ubiquitination and deubiquitination.
    Neutzner M; Neutzner A
    Essays Biochem; 2012; 52():37-50. PubMed ID: 22708562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of Genome through Variative Nature of Histone-Modifying Ubiquitin Ligases.
    Bacheva AV; Gotmanova NN; Belogurov AA; Kudriaeva AA
    Biochemistry (Mosc); 2021 Jan; 86(Suppl 1):S71-S95. PubMed ID: 33827401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dictyostelium as model for studying ubiquitination and deubiquitination.
    Pergolizzi B; Bozzaro S; Bracco E
    Int J Dev Biol; 2019; 63(8-9-10):529-539. PubMed ID: 31840790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.